Probiotics Lactobacillus reuteri Abrogates Immune Checkpoint Blockade-Associated Colitis by Inhibiting Group 3 Innate Lymphoid Cells

Immune checkpoint blockade (ICB) immunotherapy increases antitumor immunity by blocking cytotoxic-T-lymphocyte-associated protein 4 (CTLA-4) or programmed cell death protein 1 (PD-1)/programmed death-ligand 1 (PD-L1) and displays robust clinical responses in various cancers. However, ICB immunothera...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Tingting, Zheng, Naisheng, Luo, Qin, Jiang, Li, He, Baokun, Yuan, Xiangliang, Shen, Lisong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558076/
https://www.ncbi.nlm.nih.gov/pubmed/31214189
http://dx.doi.org/10.3389/fimmu.2019.01235

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6558076/
https://www.ncbi.nlm.nih.gov/pubmed/31214189
http://dx.doi.org/10.3389/fimmu.2019.01235

Ejemplares similares